Camille P Vaughan Selected Research

Pharmaceutical Preparations

12/2020	Comorbidities, Age, and Polypharmacy Limit the Use by US Older Adults with Nocturia of the Only FDA-approved Drugs for the Symptom.
12/2016	A case of lithium-induced parkinsonism presenting with typical motor symptoms of Parkinson's disease in a bipolar patient.
10/2016	Pilot Results from a Randomized Trial in Men Comparing Alpha-Adrenergic Antagonist versus Behavior and Exercise for Nocturia and Sleep.
12/2011	Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial.
7/2009	A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Camille P Vaughan Research Topics

Disease

8	Urinary Incontinence 01/2022 - 06/2013
7	Nocturia 01/2022 - 07/2009
5	Overactive Urinary Bladder (Overactive Bladder) 01/2022 - 12/2011
4	Parkinson Disease (Parkinson's Disease) 01/2022 - 05/2015
2	Cognitive Dysfunction 01/2022 - 10/2021
2	Dementia (Dementias) 10/2021 - 01/2019
2	Constipation 01/2019 - 05/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021
1	Alcoholism (Alcohol Abuse) 12/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Orthostatic Hypotension (Postural Hypotension) 01/2019
1	Urinary Retention 01/2019
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 05/2017
1	Type 2 Diabetes Mellitus (MODY) 05/2017
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2016
1	Parkinsonian Disorders (Parkinsonism) 12/2016
1	Edema (Dropsy) 10/2016
1	Fecal Incontinence 02/2016
1	Xerostomia 05/2015
1	Diarrhea 05/2015
1	Pelvic Floor Disorders 01/2014
1	Lower Urinary Tract Symptoms 12/2011
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 12/2011
1	Vitamin D Deficiency 12/2011

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 12/2020 - 07/2009
4	Vitamin D FDA LinkGeneric 01/2021 - 12/2011
2	Tamsulosin (Flomax)FDA LinkGeneric 01/2021 - 10/2016
2	Metformin (Glucophage)FDA LinkGeneric 12/2020 - 05/2017
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2019 - 07/2013
2	Adrenergic Antagonists (Antiadrenergic Agents)IBA 10/2016 - 07/2013
2	Muscarinic AntagonistsIBA 07/2013 - 12/2011
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 12/2020
1	SodiumIBA 12/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2020
1	Aligeron (AS 2)IBA 01/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2019
1	LithiumIBA 12/2016
1	TabletsIBA 10/2016
1	A-factor (Streptomyces)IBA 02/2016
1	Solifenacin Succinate FDA Link 05/2015
1	Coffee FDA Link 06/2013
1	Caffeine (No Doz)FDA LinkGeneric 06/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2009
5	Drug Therapy (Chemotherapy) 01/2020 - 07/2009
3	Exercise Therapy (Therapy, Exercise) 01/2022 - 07/2013
2	Hysterectomy 05/2015 - 01/2014
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Activities of Daily Living (ADL) 10/2021
1	Self-Help Devices (Assistive Technology) 10/2021
1	Polypharmacy 12/2020
1	Contraindications 12/2020
1	Institutionalization (Institutionalized Persons) 01/2019
1	Aftercare (After-Treatment) 05/2015